GLOBUS MEDICAL, INC. Unrealized Gain (Loss) on Derivatives
GLOBUS MEDICAL, INC. (GMED) reported Unrealized Gain (Loss) on Derivatives of $0 for the 12-month period ending 2012-12-31, per its 10-K/A filed 2013-06-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2013-06-13
- GLOBUS MEDICAL, INC. unrealized gain (loss) on derivatives for the quarter ending 2012-12-31 was $0.00.
- GLOBUS MEDICAL, INC. unrealized gain (loss) on derivatives for the quarter ending 2012-09-30 was $0.00.
- GLOBUS MEDICAL, INC. unrealized gain (loss) on derivatives for the quarter ending 2011-12-31 was $0.00.
- GLOBUS MEDICAL, INC. unrealized gain (loss) on derivatives for the quarter ending 2011-09-30 was $0.00.
- GLOBUS MEDICAL, INC. unrealized gain (loss) on derivatives for fiscal 2012 was $0.00.
- GLOBUS MEDICAL, INC. unrealized gain (loss) on derivatives for fiscal 2011 was -$113.00K, a 147.48% decline from fiscal 2010.
- GLOBUS MEDICAL, INC. unrealized gain (loss) on derivatives for fiscal 2010 was $238.00K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-06-13 | $0.00 derived: sum of 2 quarters · filed 2013-06-13 | $0.00 10-K/A · filed 2013-06-13 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-02 | $0.00 10-Q · filed 2012-11-02 | ||
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-19 | |||
| 2011-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-06-13 | $0.00 derived: sum of 2 quarters · filed 2013-06-13 | -$113.00K 10-K/A · filed 2013-06-13 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-02 | -$113.00K 10-Q · filed 2012-11-02 | ||
| 2011-06-30 | -$113.00K 10-Q/A · filed 2012-09-19 | |||
| 2010-12-31 | $238.00K 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |